{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:34:57Z","timestamp":1791920097712,"version":"4.3.4"},"reference-count":151,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T00:00:00Z","timestamp":1629158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Dutch Kidney Foundation and VIFOR"},{"name":"Silence Therapeutics UK for a program targeting hepcidin synthesis. V.N. Subramaniam is in receipt of a Senior Research Fellowship from the National Health and Medical Research Council of Australia","award":["APP1118888"],"award-info":[{"award-number":["APP1118888"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Hereditary hemochromatosis (HH) is a genetic disease, leading to iron accumulation and possible organ damage. Patients are usually homozygous for p. Cys282Tyr in the homeostatic iron regulator gene but may have mutations in other genes involved in the regulation of iron. Next-generation sequencing is increasingly being utilized for the diagnosis of patients, leading to the discovery of novel genetic variants. The clinical significance of these variants is often unknown.<\/jats:p><\/jats:sec><jats:sec><jats:title>Content<\/jats:title><jats:p>Determining the pathogenicity of such variants of unknown significance is important for diagnostics and genetic counseling. Predictions can be made using in silico computational tools and population data, but additional evidence is required for a conclusive pathogenicity classification. Genetic disease models, such as in vitro models using cellular overexpression, induced pluripotent stem cells or organoids, and in vivo models using mice or zebrafish all have their own challenges and opportunities when used to model HH and other iron disorders. Recent developments in gene-editing technologies are transforming the field of genetic disease modeling.<\/jats:p><\/jats:sec><jats:sec><jats:title>Summary<\/jats:title><jats:p>In summary, this review addresses methods and developments regarding the discovery and classification of genetic variants, from in silico tools to in vitro and in vivo models, and presents them in the context of HH. It also explores recent gene-editing developments and how they can be applied to the discussed models of genetic disease.<\/jats:p><\/jats:sec>","DOI":"10.1093\/clinchem\/hvab130","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T11:08:35Z","timestamp":1624532915000},"page":"1324-1341","source":"Crossref","is-referenced-by-count":10,"title":["Genetic Diagnosis in Hereditary Hemochromatosis: Discovering and Understanding the Biological Relevance of Variants"],"prefix":"10.1093","volume":"67","author":[{"given":"Floor S","family":"Baas","sequence":"first","affiliation":[{"name":"Translational Metabolic Laboratory (TML 831), Radboudumc, Nijmegen, the Netherlands"},{"name":"Hepatogenomics Research Group, School of Biomedical Sciences, Queensland University of Technology (QUT), Brisbane, QLD, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautam","family":"Rishi","sequence":"additional","affiliation":[{"name":"Hepatogenomics Research Group, School of Biomedical Sciences, Queensland University of Technology (QUT), Brisbane, QLD, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorine W","family":"Swinkels","sequence":"additional","affiliation":[{"name":"Translational Metabolic Laboratory (TML 831), Radboudumc, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4583-7790","authenticated-orcid":false,"given":"V Nathan","family":"Subramaniam","sequence":"additional","affiliation":[{"name":"Hepatogenomics Research Group, School of Biomedical Sciences, Queensland University of Technology (QUT), Brisbane, QLD, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,8,17]]},"reference":[{"key":"2021100117522151100_hvab130-B1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cell.2016.12.034","article-title":"A red carpet for iron metabolism","volume":"168","author":"Muckenthaler","year":"2017","journal-title":"Cell"},{"key":"2021100117522151100_hvab130-B2","doi-asserted-by":"crossref","first-page":"118535","DOI":"10.1016\/j.bbamcr.2019.118535","article-title":"Iron homeostasis and oxidative stress: an intimate relationship","volume":"1866","author":"Galaris","year":"2019","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"2021100117522151100_hvab130-B3","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization","volume":"306","author":"Nemeth","year":"2004","journal-title":"Science"},{"key":"2021100117522151100_hvab130-B4","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41586-020-2668-z","article-title":"Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms","volume":"586","author":"Billesb\u00f8lle","year":"2020","journal-title":"Nature"},{"key":"2021100117522151100_hvab130-B5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/bs.vh.2019.01.003","article-title":"Signaling pathways regulating hepcidin","volume":"110","author":"Rishi","year":"2019","journal-title":"Vitam Horm"},{"key":"2021100117522151100_hvab130-B6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1182\/blood-2016-06-721571","article-title":"Endothelial cells produce bone morphogenetic protein 6 required for iron homeostasis in mice","volume":"129","author":"Canali","year":"2017","journal-title":"Blood"},{"key":"2021100117522151100_hvab130-B7","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/ajh.24888","article-title":"Bone morphogenetic protein 2 controls iron homeostasis in mice independent of Bmp6","volume":"92","author":"Canali","year":"2017","journal-title":"Am J Hematol"},{"key":"2021100117522151100_hvab130-B8","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.cmet.2008.09.012","article-title":"The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin","volume":"8","author":"Silvestri","year":"2008","journal-title":"Cell Metab"},{"key":"2021100117522151100_hvab130-B9","doi-asserted-by":"crossref","first-page":"18354","DOI":"10.1074\/jbc.M117.801795","article-title":"Matriptase-2 suppresses hepcidin expression by cleaving multiple components of the hepcidin induction pathway","volume":"292","author":"Wahedi","year":"2017","journal-title":"J Biol Chem"},{"key":"2021100117522151100_hvab130-B10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.bcmd.2011.04.009","article-title":"Liver hemojuvelin protein levels in mice deficient in matriptase-2 (Tmprss6)","volume":"47","author":"Krijt","year":"2011","journal-title":"Blood Cells Mol Dis"},{"key":"2021100117522151100_hvab130-B11","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1074\/jbc.RA118.006468","article-title":"The catalytic, stem, and transmembrane portions of matriptase-2 are required for suppressing the expression of the iron-regulatory hormone hepcidin","volume":"294","author":"Mao","year":"2019","journal-title":"J Biol Chem"},{"key":"2021100117522151100_hvab130-B12","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1182\/blood.2020005222","article-title":"The ectodomain of matriptase-2 plays an important nonproteolytic role in suppressing hepcidin expression in mice","volume":"136","author":"Enns","year":"2020","journal-title":"Blood"},{"key":"2021100117522151100_hvab130-B13","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1373\/clinchem.2006.068684","article-title":"Hereditary hemochromatosis: genetic complexity and new diagnostic approaches","volume":"52","author":"Swinkels","year":"2006","journal-title":"Clin Chem"},{"key":"2021100117522151100_hvab130-B14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fnut.2018.00103","article-title":"Inherited disorders of iron overload","volume":"5","author":"Pantopoulos","year":"2018","journal-title":"Front Nutr"},{"key":"2021100117522151100_hvab130-B15","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S0140-6736(15)01315-X","article-title":"Haemochromatosis","volume":"388","author":"Powell","year":"2016","journal-title":"Lancet"},{"key":"2021100117522151100_hvab130-B16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13256-017-1526-6","article-title":"Reversal of end-stage heart failure in juvenile hemochromatosis with iron chelation therapy: a case report","volume":"12","author":"Cooray","year":"2018","journal-title":"J Med Case Rep"},{"key":"2021100117522151100_hvab130-B17","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/hep.22972","article-title":"HFE C282Y\/H63D compound heterozygotes are at low risk of hemochromatosis-related morbidity","volume":"50","author":"Gurrin","year":"2009","journal-title":"Hepatology"},{"key":"2021100117522151100_hvab130-B18","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jhep.2018.09.009","article-title":"Reduced phenotypic expression in genetic hemochromatosis with time: role of exposure to non-genetic modifiers","volume":"70","author":"Deugnier","year":"2019","journal-title":"J Hepatol"},{"key":"2021100117522151100_hvab130-B19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.21037\/tgh.2019.11.15","article-title":"Inherited iron overload disorders","volume":"5","author":"Piperno","year":"2020","journal-title":"Transl Gastroenterol Hepatol"},{"key":"2021100117522151100_hvab130-B20","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/gim.2015.140","article-title":"The global prevalence of HFE and non-HFE hemochromatosis estimated from analysis of next-generation sequencing data","volume":"18","author":"Wallace","year":"2016","journal-title":"Genet Med"},{"key":"2021100117522151100_hvab130-B21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1182\/blood-2018-02-830562","article-title":"Phenotypic analysis of hemochromatosis subtypes reveals variations in severity of iron overload and clinical disease","volume":"132","author":"Sandhu","year":"2018","journal-title":"Blood"},{"key":"2021100117522151100_hvab130-B22","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3390\/ph12030132","article-title":"Twenty years of ferroportin disease: a review or an update of published clinical, biochemical, molecular, and functional features","volume":"12","author":"Vlasveld","year":"2019","journal-title":"Pharmaceuticals (Basel"},{"key":"2021100117522151100_hvab130-B23","doi-asserted-by":"crossref","first-page":"355","DOI":"10.5334\/tohm.317","article-title":"Neuroferritinopathy: pathophysiology, presentation, differential diagnoses and management","volume":"6","author":"Kumar","year":"2016","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"2021100117522151100_hvab130-B24","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/1479-7364-4-4-250","article-title":"Hyperferritinaemia-cataract syndrome: worldwide mutations and phenotype of an increasingly diagnosed genetic disorder","volume":"4","author":"Millonig","year":"2010","journal-title":"Hum Genomics"},{"key":"2021100117522151100_hvab130-B25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1086\/321261","article-title":"A mutation, in the iron-responsive element of H ferritin mRNA, causing autosomal dominant iron overload","volume":"69","author":"Kato","year":"2001","journal-title":"Am J Hum Genet"},{"key":"2021100117522151100_hvab130-B26","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3324\/haematol.2008.000125","article-title":"A new missense mutation in the L ferritin coding sequence associated with elevated levels of glycosylated ferritin in serum and absence of iron overload","volume":"94","author":"Kannengiesser","year":"2009","journal-title":"Haematologica"},{"key":"2021100117522151100_hvab130-B27","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/ajh.24730","article-title":"Identification of new BMP6 pro-peptide mutations in patients with iron overload","volume":"92","author":"Piubelli","year":"2017","journal-title":"Am J Hematol"},{"key":"2021100117522151100_hvab130-B28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.clinre.2019.09.007","article-title":"Mutations and polymorphisms associated with iron overload in a series of 91 non-HFE haemochromatosis patients","volume":"44","author":"Borgel","year":"2020","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"2021100117522151100_hvab130-B29","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1086\/520001","article-title":"Common variants in the BMP2, BMP4, and HJV genes of the hepcidin regulation pathway modulate HFE hemochromatosis penetrance","volume":"81","author":"Milet","year":"2007","journal-title":"Am J Hum Genet"},{"key":"2021100117522151100_hvab130-B30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40246-018-0155-5","article-title":"Evaluation of a bone morphogenetic protein 6 variant as a cause of iron loading","volume":"12","author":"McDonald","year":"2018","journal-title":"Hum Genomics"},{"key":"2021100117522151100_hvab130-B31","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bcmd.2015.04.001","article-title":"Hereditary hemochromatosis type 1 phenotype modifiers in Italian patients. The controversial role of variants in HAMP, BMP2, FTL and SLC40A1 genes","volume":"55","author":"Radio","year":"2015","journal-title":"Blood Cells Mol Dis"},{"key":"2021100117522151100_hvab130-B32","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.bcmd.2016.07.004","article-title":"Next-generation sequencing of hereditary hemochromatosis-related genes: novel likely pathogenic variants found in the Portuguese population","volume":"61","author":"Faria","year":"2016","journal-title":"Blood Cells Mol Dis"},{"key":"2021100117522151100_hvab130-B33","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/ajh.24304","article-title":"Identification of novel mutations in hemochromatosis genes by targeted next generation sequencing in Italian patients with unexplained iron overload","volume":"91","author":"Badar","year":"2016","journal-title":"Am J Hematol"},{"key":"2021100117522151100_hvab130-B34","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jhep.2015.06.027","article-title":"Next-generation sequencing: application of a novel platform to analyze atypical iron disorders","volume":"63","author":"McDonald","year":"2015","journal-title":"J Hepatol"},{"key":"2021100117522151100_hvab130-B35","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/ejh.12820","article-title":"Clinical evaluation of a hemochromatosis next-generation sequencing gene panel","volume":"98","author":"Lanktree","year":"2017","journal-title":"Eur J Haematol"},{"key":"2021100117522151100_hvab130-B36","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1093\/hmg\/ddg225","article-title":"Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis","volume":"12","author":"Merryweather-Clarke","year":"2003","journal-title":"Hum Mol Genet"},{"key":"2021100117522151100_hvab130-B37","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1053\/j.gastro.2004.11.057","article-title":"Juvenile hemochromatosis associated with pathogenic mutations of adult hemochromatosis genes","volume":"128","author":"Pietrangelo","year":"2005","journal-title":"Gastroenterology"},{"key":"2021100117522151100_hvab130-B38","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1080\/17474124.2018.1496016","article-title":"Hemochromatosis: pathophysiology, evaluation, and management of hepatic iron overload with a focus on MRI","volume":"12","author":"Golfeyz","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"2021100117522151100_hvab130-B39","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1002\/cpmb.59","article-title":"Overview of next-generation sequencing technologies","volume":"122","author":"Slatko","year":"2018","journal-title":"Curr Protoc Mol Biol"},{"key":"2021100117522151100_hvab130-B40","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nrg.2016.49","article-title":"Coming of age: ten years of next-generation sequencing technologies","volume":"17","author":"Goodwin","year":"2016","journal-title":"Nat Rev Genet"},{"key":"2021100117522151100_hvab130-B41","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/bfgp\/elr033","article-title":"Targeted enrichment of genomic DNA regions for next-generation sequencing","volume":"10","author":"Mertes","year":"2011","journal-title":"Brief Funct Genomics"},{"key":"2021100117522151100_hvab130-B42","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1136\/jmedgenet-2011-100223","article-title":"What can exome sequencing do for you?","volume":"48","author":"Majewski","year":"2011","journal-title":"J Med Genet"},{"key":"2021100117522151100_hvab130-B43","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nature08250","article-title":"Targeted capture and massively parallel sequencing of 12 human exomes","volume":"461","author":"Ng","year":"2009","journal-title":"Nature"},{"key":"2021100117522151100_hvab130-B44","first-page":"57266","article-title":"Targeted next-generation sequencing and bioinformatics pipeline to evaluate genetic determinants of constitutional disease","volume":"4","author":"Dilliott","year":"2018","journal-title":"J Vis Exp"},{"key":"2021100117522151100_hvab130-B45","first-page":"67","article-title":"Review of current methods, applications, and data management for the bioinformatics analysis of whole exome sequencing","volume":"13","author":"Bao","year":"2014","journal-title":"Cancer Inform"},{"key":"2021100117522151100_hvab130-B46","volume-title":"Practice guidelines for the evaluation of pathogenicity and the reporting of sequence variants in clinical molecular genetics","author":"Wallis","year":"2013"},{"key":"2021100117522151100_hvab130-B47","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"2021100117522151100_hvab130-B48","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1373\/clinchem.2007.090605","article-title":"Global sequencing approach for characterizing the molecular background of hereditary iron disorders","volume":"53","author":"Cunat","year":"2007","journal-title":"Clin Chem"},{"key":"2021100117522151100_hvab130-B49","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000337034","article-title":"Mild iron overload in an African American man with SLC40A1 D270V","volume":"128","author":"Lee","year":"2012","journal-title":"Acta Haematol"},{"key":"2021100117522151100_hvab130-B50","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/hep.27711","article-title":"Exome sequencing in HFE C282Y homozygous men with extreme phenotypes identifies a GNPAT variant associated with severe iron overload","volume":"62","author":"McLaren","year":"2015","journal-title":"Hepatology"},{"key":"2021100117522151100_hvab130-B51","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/ajh.24844","article-title":"The dynamics of hepcidin-ferroportin internalization and consequences of a novel ferroportin disease mutation","volume":"92","author":"Wallace","year":"2017","journal-title":"Am J Hematol"},{"key":"2021100117522151100_hvab130-B52","doi-asserted-by":"crossref","first-page":"E664","DOI":"10.1002\/ajh.24912","article-title":"Diagnostic value of targeted next-generation sequencing in suspected hemochromatosis patients with a single copy of the HFE p.Cys282Tyr causative allele","volume":"92","author":"Uguen","year":"2017","journal-title":"Am J Hematol"},{"key":"2021100117522151100_hvab130-B53","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/vox.12619","article-title":"Causes of iron overload in blood donors: a clinical study","volume":"113","author":"Laursen","year":"2018","journal-title":"Vox Sang"},{"key":"2021100117522151100_hvab130-B54","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1136\/jmedgenet-2018-105348","article-title":"Non-HFE mutations in haemochromatosis in China: combination of heterozygous mutations involving HJV signal peptide variants","volume":"55","author":"Lv","year":"2018","journal-title":"J Med Genet"},{"key":"2021100117522151100_hvab130-B55","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jceh.2019.04.051","article-title":"Hemochromatosis in India: first report of whole exome sequencing with review of the literature","volume":"10","author":"Koshy","year":"2020","journal-title":"J Clin Exp Hepatol"},{"key":"2021100117522151100_hvab130-B56","doi-asserted-by":"crossref","first-page":"31982","DOI":"10.1002\/hep.31982","article-title":"MRI-based iron phenotyping and patient selection for next-generation sequencing of non-HFE hemochromatosis genes","author":"Viveiros","year":"2021","journal-title":"Hepatology"},{"key":"2021100117522151100_hvab130-B57","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1002\/hep.28259","article-title":"Further support for the association of GNPAT variant rs11558492 with severe iron overload in hemochromatosis","volume":"63","author":"Besson-Fournier","year":"2016","journal-title":"Hepatology"},{"key":"2021100117522151100_hvab130-B58","doi-asserted-by":"crossref","first-page":"451","DOI":"10.5604\/01.3001.0009.8601","article-title":"GNPAT rs11558492 is not a major modifier of iron status: study of Italian hemochromatosis patients and blood donors","volume":"16","author":"Greni","year":"2017","journal-title":"Ann Hepatol"},{"key":"2021100117522151100_hvab130-B59","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1111\/jcmm.15068","article-title":"Gnpat does not play an essential role in systemic iron homeostasis in murine model","volume":"24","author":"An","year":"2020","journal-title":"J Cell Mol Med"},{"key":"2021100117522151100_hvab130-B60","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1365-2141.2009.07843.x","article-title":"A novel association between a SNP in CYBRD1 and serum ferritin levels in a cohort study of HFE hereditary haemochromatosis","volume":"147","author":"Constantine","year":"2009","journal-title":"Br J Haematol"},{"key":"2021100117522151100_hvab130-B61","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/ajh.21524","article-title":"HFE, SLC40A1, HAMP, HJV, TFR2, and FTLmutations detected by denaturing high-performance liquid chromatography after iron phenotyping and HFEC282Y and H63D genotyping in 785 HEIRS Study participants","volume":"84","author":"Barton","year":"2009","journal-title":"Am J Hematol"},{"key":"2021100117522151100_hvab130-B62","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.3324\/haematol.2012.062661","article-title":"CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.C282Y homozygous patients","volume":"97","author":"Pelucchi","year":"2012","journal-title":"Haematologica"},{"key":"2021100117522151100_hvab130-B63","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.jhep.2014.10.017","article-title":"Genome-wide association study identifies TF as a significant modifier gene of iron metabolism in HFE hemochromatosis","volume":"62","author":"de Tayrac","year":"2015","journal-title":"J Hepatol"},{"key":"2021100117522151100_hvab130-B64","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat Methods"},{"key":"2021100117522151100_hvab130-B65","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1093\/nar\/gkg509","article-title":"SIFT: Predicting amino acid changes that affect protein function","volume":"31","author":"Ng","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"2021100117522151100_hvab130-B66","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nmeth0810-575","article-title":"MutationTaster evaluates disease-causing potential of sequence alterations","volume":"7","author":"Schwarz","year":"2010","journal-title":"Nat Methods"},{"key":"2021100117522151100_hvab130-B67","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/humu.10235","article-title":"A phylogenetic approach to assessing the significance of missense mutations in disease genes","volume":"22","author":"Santib\u00e1\u00f1ez Koref","year":"2003","journal-title":"Hum Mutat"},{"key":"2021100117522151100_hvab130-B68","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1093\/hmg\/10.21.2319","article-title":"Understanding human disease mutations through the use of interspecific genetic variation","volume":"10","author":"Miller","year":"2001","journal-title":"Hum Mol Genet"},{"key":"2021100117522151100_hvab130-B69","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.sbi.2010.03.006","article-title":"Human allelic variation: perspective from protein function, structure, and evolution","volume":"20","author":"Jordan","year":"2010","journal-title":"Curr Opin Struct Biol"},{"key":"2021100117522151100_hvab130-B70","doi-asserted-by":"crossref","first-page":"W306","DOI":"10.1093\/nar\/gki375","article-title":"I-Mutant2.0: predicting stability changes upon mutation from the protein sequence or structure","volume":"33","author":"Capriotti","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"2021100117522151100_hvab130-B71","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/prot.20810","article-title":"Prediction of protein stability changes for single-site mutations using support vector machines","volume":"62","author":"Cheng","year":"2006","journal-title":"Proteins"},{"key":"2021100117522151100_hvab130-B72","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature09534","article-title":"A map of human genome variation from population-scale sequencing","volume":"467","author":"Abecasis","year":"2010","journal-title":"Nature"},{"key":"2021100117522151100_hvab130-B73","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/ng.3810","article-title":"Fast, scalable prediction of deleterious noncoding variants from functional and population genomic data","volume":"49","author":"Huang","year":"2017","journal-title":"Nat Genet"},{"key":"2021100117522151100_hvab130-B74","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12920-018-0455-6","article-title":"Computational identification of deleterious synonymous variants in human genomes using a feature-based approach","volume":"12","author":"Shi","year":"2019","journal-title":"BMC Med Genomics"},{"key":"2021100117522151100_hvab130-B75","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/bioinformatics\/btu765","article-title":"Identification of deleterious synonymous variants in human genomes","volume":"31","author":"Buske","year":"2015","journal-title":"Bioinformatics"},{"key":"2021100117522151100_hvab130-B76","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/gim.2013.176","article-title":"In silico tools for splicing defect prediction: a survey from the viewpoint of end users","volume":"16","author":"Jian","year":"2014","journal-title":"Genet Med"},{"key":"2021100117522151100_hvab130-B77","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40246-017-0104-8","article-title":"Variant effect prediction tools assessed using independent, functional assay-based datasets: implications for discovery and diagnostics","volume":"11","author":"Mahmood","year":"2017","journal-title":"Hum Genomics"},{"key":"2021100117522151100_hvab130-B78","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/humu.22768","article-title":"The evaluation of tools used to predict the impact of missense variants is hindered by two types of circularity","volume":"36","author":"Grimm","year":"2015","journal-title":"Hum Mutat"},{"key":"2021100117522151100_hvab130-B79","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1111\/liv.14539","article-title":"Reduced iron export associated with hepcidin resistance can explain the iron overload spectrum in ferroportin disease","volume":"40","author":"Viveiros","year":"2020","journal-title":"Liver Int"},{"key":"2021100117522151100_hvab130-B80","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/mgg3.136","article-title":"Functional consequences of transferrin receptor-2 mutations causing hereditary hemochromatosis type 3","volume":"3","author":"Joshi","year":"2015","journal-title":"Mol Genet Genomic Med"},{"key":"2021100117522151100_hvab130-B81","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.bcmd.2013.07.011","article-title":"Phenotypic expression of a novel C282Y\/R226G compound heterozygous state in HFE hemochromatosis: molecular dynamics and biochemical studies","volume":"52","author":"C\u00e9zard","year":"2014","journal-title":"Blood Cells Mol Dis"},{"key":"2021100117522151100_hvab130-B82","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.3324\/haematol.12508","article-title":"Hemojuvelin N-terminal mutants reach the plasma membrane but do not activate the hepcidin response","volume":"93","author":"Pagani","year":"2008","journal-title":"Haematologica"},{"key":"2021100117522151100_hvab130-B83","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1053\/j.gastro.2015.10.049","article-title":"Heterozygous mutations in BMP6 pro-peptide lead to inappropriate hepcidin synthesis and moderate iron overload in humans","volume":"150","author":"Daher","year":"2016","journal-title":"Gastroenterology"},{"key":"2021100117522151100_hvab130-B84","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nmeth.2534","article-title":"The transience of transient overexpression","volume":"10","author":"Gibson","year":"2013","journal-title":"Nat Methods"},{"key":"2021100117522151100_hvab130-B85","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/ncb2175","article-title":"Rapid and efficient clathrin-mediated endocytosis revealed in genome-edited mammalian cells","volume":"13","author":"Doyon","year":"2011","journal-title":"Nat Cell Biol"},{"key":"2021100117522151100_hvab130-B86","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1091\/mbc.e14-06-1091","article-title":"Comparative assessment of fluorescent transgene methods for quantitative imaging in human cells","volume":"25","author":"Mahen","year":"2014","journal-title":"Mol Biol Cell"},{"key":"2021100117522151100_hvab130-B87","doi-asserted-by":"crossref","first-page":"e77267","DOI":"10.1371\/journal.pone.0077267","article-title":"In situ proximity ligation assays indicate that hemochromatosis proteins Hfe and transferrin receptor 2 (Tfr2) do not interact","volume":"8","author":"Rishi","year":"2013","journal-title":"PLoS One"},{"key":"2021100117522151100_hvab130-B88","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/ajh.23173","article-title":"Transgenic HFE-dependent induction of hepcidin in mice does not require transferrin receptor-2","volume":"87","author":"Schmidt","year":"2012","journal-title":"Am J Hematol"},{"key":"2021100117522151100_hvab130-B89","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.tig.2018.05.004","article-title":"Gene editing on center stage","volume":"34","author":"Bak","year":"2018","journal-title":"Trends Genet"},{"key":"2021100117522151100_hvab130-B90","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","article-title":"Genome editing with CRISPR\u2013Cas nucleases, base editors, transposases and prime editors","volume":"38","author":"Anzalone","year":"2020","journal-title":"Nat Biotechnol"},{"key":"2021100117522151100_hvab130-B91","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jprot.2016.01.016","article-title":"In-depth quantitative analysis and comparison of the human hepatocyte and hepatoma cell line HepG2 proteomes","volume":"136","author":"Wi\u015bniewski","year":"2016","journal-title":"J Proteomics"},{"key":"2021100117522151100_hvab130-B92","doi-asserted-by":"crossref","first-page":"12562","DOI":"10.1038\/s41598-018-30618-z","article-title":"Functional diversity of TMPRSS6 isoforms and variants expressed in hepatocellular carcinoma cell lines","volume":"8","author":"Dion","year":"2018","journal-title":"Sci Rep"},{"key":"2021100117522151100_hvab130-B93","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cmet.2009.01.010","article-title":"Interaction of the hereditary hemochromatosis protein HFE with transferrin receptor 2 is required for transferrin-induced hepcidin expression","volume":"9","author":"Gao","year":"2009","journal-title":"Cell Metab"},{"key":"2021100117522151100_hvab130-B94","doi-asserted-by":"crossref","first-page":"768391","DOI":"10.1155\/2014\/768391","article-title":"A comparative view on human somatic cell sources for iPSC generation","volume":"2014","author":"Raab","year":"2014","journal-title":"Stem Cells Int"},{"key":"2021100117522151100_hvab130-B95","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/nature22403","article-title":"Common genetic variation drives molecular heterogeneity in human iPSCs","volume":"546","author":"Kilpinen","year":"2017","journal-title":"Nature"},{"key":"2021100117522151100_hvab130-B96","doi-asserted-by":"crossref","first-page":"e1005793","DOI":"10.1371\/journal.pgen.1005793","article-title":"Genetic variation, not cell type of origin, underlies the majority of identifiable regulatory differences in iPSCs","volume":"12","author":"Burrows","year":"2016","journal-title":"PloS Genet"},{"key":"2021100117522151100_hvab130-B97","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1161\/CIRCULATIONAHA.117.032273","article-title":"Determining the pathogenicity of a genomic variant of uncertain significance using CRISPR\/Cas9 and human-induced pluripotent stem cells","volume":"138","author":"Ma","year":"2018","journal-title":"Circulation"},{"key":"2021100117522151100_hvab130-B98","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/ejn.14345","article-title":"Induced pluripotent stem cell-based modeling of mutant LRRK2-associated Parkinson\u2019s disease","volume":"49","author":"Weykopf","year":"2019","journal-title":"Eur J Neurosci"},{"key":"2021100117522151100_hvab130-B99","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s13238-017-0397-3","article-title":"CRISPR\/Cas9-mediated targeted gene correction in amyotrophic lateral sclerosis patient iPSCs","volume":"8","author":"Wang","year":"2017","journal-title":"Protein Cell"},{"key":"2021100117522151100_hvab130-B100","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.stem.2017.01.010","article-title":"Induced pluripotent stem cell differentiation enables functional validation of GWAS variants in metabolic disease","volume":"20","author":"Warren","year":"2017","journal-title":"Cell Stem Cell"},{"key":"2021100117522151100_hvab130-B101","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3390\/genes11050511","article-title":"Efficient generation and correction of mutations in human iPS cells utilizing mRNAs of CRISPR base editors and prime editors","volume":"11","author":"S\u00fcr\u00fcn","year":"2020","journal-title":"Genes"},{"key":"2021100117522151100_hvab130-B102","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.neuron.2019.11.010","article-title":"A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP \u03b2-CTFs, not A\u03b2","volume":"104","author":"Kwart","year":"2019","journal-title":"Neuron"},{"key":"2021100117522151100_hvab130-B103","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/s41588-019-0497-5","article-title":"Synergistic effects of common schizophrenia risk variants","volume":"51","author":"Schrode","year":"2019","journal-title":"Nat Genet"},{"key":"2021100117522151100_hvab130-B104","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/cvr\/cvaa019","article-title":"MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes","volume":"117","author":"Lee","year":"2021","journal-title":"Cardiovasc Res"},{"key":"2021100117522151100_hvab130-B105","doi-asserted-by":"crossref","first-page":"14.13.1","DOI":"10.1002\/0471140856.tx1413s67","article-title":"The use of induced pluripotent stem cells for the study and treatment of liver diseases","volume":"67","author":"Hansel","year":"2016","journal-title":"Curr Protoc Toxicol"},{"key":"2021100117522151100_hvab130-B106","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/j.celrep.2018.01.087","article-title":"A roadmap for human liver differentiation from pluripotent stem cells","volume":"22","author":"Ang","year":"2018","journal-title":"Cell Rep"},{"key":"2021100117522151100_hvab130-B107","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/stem.3154","article-title":"Advances in generating liver cells from pluripotent stem cells as a tool for modeling liver diseases","volume":"38","author":"Maepa","year":"2020","journal-title":"Stem Cells"},{"key":"2021100117522151100_hvab130-B108","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3390\/ijms19040936","article-title":"Disease modeling using 3D organoids derived from human induced pluripotent stem cells","volume":"19","author":"Ho","year":"2018","journal-title":"Int J Mol Sci"},{"key":"2021100117522151100_hvab130-B109","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature12271","article-title":"Vascularized and functional human liver from an iPSC-derived organ bud transplant","volume":"499","author":"Takebe","year":"2013","journal-title":"Nature"},{"key":"2021100117522151100_hvab130-B110","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.jhep.2018.12.028","article-title":"Generation of hepatobiliary organoids from human induced pluripotent stem cells","volume":"70","author":"Wu","year":"2019","journal-title":"J Hepatol"},{"key":"2021100117522151100_hvab130-B111","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.stemcr.2019.08.007","article-title":"Robust, long-term culture of endoderm-derived hepatic organoids for disease modeling","volume":"13","author":"Akbari","year":"2019","journal-title":"Stem Cell Rep"},{"key":"2021100117522151100_hvab130-B112","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.ajhg.2018.03.014","article-title":"Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype and reveal underlying pathogenetic mechanisms","volume":"102","author":"Forbes","year":"2018","journal-title":"Am J Hum Genet"},{"key":"2021100117522151100_hvab130-B113","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.stemcr.2019.01.020","article-title":"Modeling G2019S-LRRK2 sporadic Parkinson\u2019s disease in 3D midbrain organoids","volume":"12","author":"Kim","year":"2019","journal-title":"Stem Cell Rep"},{"key":"2021100117522151100_hvab130-B114","doi-asserted-by":"crossref","first-page":"e94954","DOI":"10.1172\/jci.insight.94954","article-title":"Human hepatic organoids for the analysis of human genetic diseases","volume":"2","author":"Guan","year":"2017","journal-title":"JCI Insight"},{"key":"2021100117522151100_hvab130-B115","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1002\/jcb.26622","article-title":"Three-dimensional liver-derived extracellular matrix hydrogel promotes liver organoids function","volume":"119","author":"Saheli","year":"2018","journal-title":"J Cell Biochem"},{"key":"2021100117522151100_hvab130-B116","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.biomaterials.2018.07.043","article-title":"Human iPS derived progenitors bioengineered into liver organoids using an inverted colloidal crystal poly (ethylene glycol) scaffold","volume":"182","author":"Ng","year":"2018","journal-title":"Biomaterials"},{"key":"2021100117522151100_hvab130-B117","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jhep.2016.07.009","article-title":"Liver sinusoidal endothelial cells: physiology and role in liver diseases","volume":"66","author":"Poisson","year":"2017","journal-title":"J Hepatol"},{"key":"2021100117522151100_hvab130-B118","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1172\/JCI66369","article-title":"Hepatic stellate cells in liver development, regeneration, and cancer","volume":"123","author":"Yin","year":"2013","journal-title":"J Clin Invest"},{"key":"2021100117522151100_hvab130-B119","doi-asserted-by":"crossref","first-page":"8920","DOI":"10.1038\/s41598-019-45514-3","article-title":"Generation of fully functional hepatocyte-like organoids from human induced pluripotent stem cells mixed with endothelial cells","volume":"9","author":"Pettinato","year":"2019","journal-title":"Sci Rep"},{"key":"2021100117522151100_hvab130-B120","doi-asserted-by":"crossref","first-page":"120091","DOI":"10.1016\/j.biomaterials.2020.120091","article-title":"Liver sinusoidal endothelial cells promote the differentiation and survival of mouse vascularised hepatobiliary organoids","volume":"251","author":"Yap","year":"2020","journal-title":"Biomaterials"},{"key":"2021100117522151100_hvab130-B121","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1177\/0963689718780332","article-title":"Functional 3D human liver bud assembled from MSC-derived multiple liver cell lineages","volume":"28","author":"Li","year":"2019","journal-title":"Cell Transplant"},{"key":"2021100117522151100_hvab130-B122","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.stem.2018.05.027","article-title":"Generation of hepatic stellate cells from human pluripotent stem cells enables in vitro modeling of liver fibrosis","volume":"23","author":"Coll","year":"2018","journal-title":"Cell Stem Cell"},{"key":"2021100117522151100_hvab130-B123","doi-asserted-by":"crossref","first-page":"6006","DOI":"10.1016\/j.biomaterials.2014.04.011","article-title":"Induced pluripotent stem cell-derived hepatocytes and endothelial cells in multi-component hydrogel fibers for liver tissue engineering","volume":"35","author":"Du","year":"2014","journal-title":"Biomaterials"},{"key":"2021100117522151100_hvab130-B124","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.stemcr.2017.06.010","article-title":"An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells","volume":"9","author":"Koui","year":"2017","journal-title":"Stem Cell Rep"},{"key":"2021100117522151100_hvab130-B125","doi-asserted-by":"crossref","first-page":"dev156166","DOI":"10.1242\/dev.156166","article-title":"Modeling human diseases with induced pluripotent stem cells: from 2D to 3D and beyond","volume":"145","author":"Liu","year":"2018","journal-title":"Development"},{"key":"2021100117522151100_hvab130-B126","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/nature01262","article-title":"Initial sequencing and comparative analysis of the mouse genome","volume":"420","year":"2002","journal-title":"Nature"},{"key":"2021100117522151100_hvab130-B127","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1242\/dmm.000901","article-title":"Technical approaches for mouse models of human disease","volume":"4","author":"Justice","year":"2011","journal-title":"Dis Model Mech"},{"key":"2021100117522151100_hvab130-B128","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0046-19.2019","article-title":"Functional assessment in vivo of the mouse homolog of the human Ala-9-Ser NHE6 variant","volume":"6","author":"Ouyang","year":"2019","journal-title":"eNeuro"},{"key":"2021100117522151100_hvab130-B129","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1093\/hmg\/ddz231","article-title":"Functional characterization of a novel PBX1 de novo missense variant identified in a patient with syndromic congenital heart disease","volume":"29","author":"Alankarage","year":"2020","journal-title":"Hum Mol Genet"},{"key":"2021100117522151100_hvab130-B130","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.cell.2013.04.025","article-title":"One-step generation of mice carrying mutations in multiple genes by CRISPR\/Cas-mediated genome engineering","volume":"153","author":"Wang","year":"2013","journal-title":"Cell"},{"key":"2021100117522151100_hvab130-B131","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1126\/science.aat5056","article-title":"Oligogenic inheritance of a human heart disease involving a genetic modifier","volume":"364","author":"Gifford","year":"2019","journal-title":"Science"},{"key":"2021100117522151100_hvab130-B132","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.cell.2020.02.031","article-title":"Comprehensive in vivo interrogation reveals phenotypic impact of human enhancer variants","volume":"180","author":"Kvon","year":"2020","journal-title":"Cell"},{"key":"2021100117522151100_hvab130-B133","doi-asserted-by":"crossref","first-page":"G157","DOI":"10.1152\/ajpgi.00004.2017","article-title":"The liver in regulation of iron homeostasis","volume":"313","author":"Rishi","year":"2017","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2021100117522151100_hvab130-B134","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1146\/annurev-nutr-072610-145117","article-title":"Knockout mouse models of iron homeostasis","volume":"31","author":"Fleming","year":"2011","journal-title":"Annu Rev Nutr"},{"key":"2021100117522151100_hvab130-B135","doi-asserted-by":"crossref","first-page":"15788","DOI":"10.1073\/pnas.2237037100","article-title":"Contribution of the H63D mutation in HFE to murine hereditary hemochromatosis","volume":"100","author":"Tomatsu","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021100117522151100_hvab130-B136","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood.V94.1.9.413a43_9_11","article-title":"The C282Y mutation causing hereditary hemochromatosis does not produce a null allele","volume":"94","author":"Levy","year":"1999","journal-title":"Blood"},{"key":"2021100117522151100_hvab130-B137","doi-asserted-by":"crossref","first-page":"10653","DOI":"10.1073\/pnas.162360699","article-title":"Targeted mutagenesis of the murine transferrin receptor-2 gene produces hemochromatosis","volume":"99","author":"Fleming","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021100117522151100_hvab130-B138","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1136\/gut.2004.062018","article-title":"First phenotypic description of transferrin receptor 2 knockout mouse, and the role of hepcidin","volume":"54","author":"Wallace","year":"2005","journal-title":"Gut"},{"key":"2021100117522151100_hvab130-B139","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1046\/j.1365-2362.2002.01026.x","article-title":"Long-term sequelae of HFE deletion in C57BL\/6 x 129\/O1a mice, an animal model for hereditary haemochromatosis","volume":"32","author":"Lebeau","year":"2002","journal-title":"Eur J Clin Invest"},{"key":"2021100117522151100_hvab130-B140","doi-asserted-by":"crossref","first-page":"e0221455","DOI":"10.1371\/journal.pone.0221455","article-title":"Mouse models of hereditary hemochromatosis do not develop early liver fibrosis in response to a high fat diet","volume":"14","author":"Wagner","year":"2019","journal-title":"PLoS One"},{"key":"2021100117522151100_hvab130-B141","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s10038-017-0346-2","article-title":"Application of genome editing technologies in rats for human disease models","volume":"63","author":"Yoshimi","year":"2018","journal-title":"J Hum Genet"},{"key":"2021100117522151100_hvab130-B142","first-page":"143","article-title":"A novel rat model of hereditary hemochromatosis due to a mutation in transferrin receptor 2","volume":"63","author":"Bartnikas","year":"2013","journal-title":"Comp Med"},{"key":"2021100117522151100_hvab130-B143","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nrg2091","article-title":"Animal models of human disease: zebrafish swim into view","volume":"8","author":"Lieschke","year":"2007","journal-title":"Nat Rev Genet"},{"key":"2021100117522151100_hvab130-B144","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature12111","article-title":"The zebrafish reference genome sequence and its relationship to the human genome","volume":"496","author":"Howe","year":"2013","journal-title":"Nature"},{"key":"2021100117522151100_hvab130-B145","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/bs.mcb.2016.10.008","article-title":"Studying disorders of vertebrate iron and heme metabolism using zebrafish","volume":"138","author":"van der Vorm","year":"2017","journal-title":"Methods Cell Biol"},{"key":"2021100117522151100_hvab130-B146","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/blood-2007-07-100248","article-title":"Zebrafish as a model for defining the functional impact of mammalian ferroportin mutations","volume":"110","author":"De Domenico","year":"2007","journal-title":"Blood"},{"key":"2021100117522151100_hvab130-B147","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.jhep.2008.05.028","article-title":"Clinical, pathological, and molecular correlates in ferroportin disease: a study of two novel mutations","volume":"49","author":"Girelli","year":"2008","journal-title":"J Hepatol"},{"key":"2021100117522151100_hvab130-B148","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1182\/blood-2009-10-251306","article-title":"Human mutation D157G in ferroportin leads to hepcidin-independent binding of Jak2 and ferroportin down-regulation","volume":"115","author":"De Domenico","year":"2010","journal-title":"Blood"},{"key":"2021100117522151100_hvab130-B149","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1182\/blood-2008-06-165340","article-title":"Transferrin-a modulates hepcidin expression in zebrafish embryos","volume":"113","author":"Fraenkel","year":"2009","journal-title":"Blood"},{"key":"2021100117522151100_hvab130-B150","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1021\/acschembio.8b00317","article-title":"Small molecule inhibitors of NFkB reverse iron overload and hepcidin deregulation in a zebrafish model for hereditary hemochromatosis type 3","volume":"13","author":"Basu","year":"2018","journal-title":"ACS Chem Biol"},{"key":"2021100117522151100_hvab130-B151","doi-asserted-by":"crossref","first-page":"e14553","DOI":"10.1371\/journal.pone.0014553","article-title":"BMP signaling modulates hepcidin expression in zebrafish embryos independent of hemojuvelin","volume":"6","author":"Gibert","year":"2011","journal-title":"PLoS One"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/67\/10\/1324\/40494880\/hvab130.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/67\/10\/1324\/40494880\/hvab130.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,5]],"date-time":"2023-11-05T08:22:17Z","timestamp":1699172537000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/67\/10\/1324\/6353352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,17]]},"references-count":151,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,8,17]]},"published-print":{"date-parts":[[2021,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/clinchem\/hvab130","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,10,1]]},"published":{"date-parts":[[2021,8,17]]}}}